Identifying and Treating Moral Injury-Based Post-traumatic Stress Disorder (PTSD) in Military Service Members and Veterans
Recorded on October 18, 2018 | 12 to 1 pm ET
Featuring: Dr. Brian Klassen
Brian Klassen, PhD, is an assistant professor of psychiatry at Rush University Medical Center and staff psychologist in the Road Home Program: Center for Veterans and Their Families. As a clinician, Dr. Klassen provides individual and group psychotherapy to both combat veterans and survivors of military sexual trauma. Dr. Klassen is particularly interested in moral injury as well as psychotherapeutic mechanisms of change. He has presented scholarly work at the annual meetings of the American Psychological Association and the Research Society on Alcoholism and he has published his research in the Journal of Traumatic Stress and the Journal of American College Health among others. A graduate of Calvin College (Grand Rapids, MI) and Wayne State University (Detroit, MI), Dr. Klassen completed his clinical training in the PTSD, substance use disorder, and chronic pain clinics of the Jesse Brown Veterans Affairs Medical Center in Chicago, IL.
Moral injury is a relatively nascent construct intended to capture reactions to events that involve the violation of service members’ and veterans’ deeply held moral beliefs. Mounting research suggests that morally injurious events may result in different PTSD symptom presentations compared to traumatic experiences that are primarily based on intense fear (i.e., life threat) or loss.
In this webinar, Dr. Klassen will provide an overview of the signs of moral injury and symptoms that appear to distinguish moral injury-based PTSD from primarily fear-based PTSD. Dr. Klassen will compare and contrast the strengths and weaknesses of different existing assessments of moral injury and provide recommendations for incorporating moral injury screenings into standard clinical intake processes.
Both existing evidence-based treatments for PTSD and novel interventions have shown promise for the treatment of moral injury-based PTSD. We will discuss the treatment mechanisms of each of these interventions and review emerging moral injury-specific treatment outcomes. We will describe in detail how existing evidence-based treatments for PTSD (i.e., Cognitive Processing Therapy and Prolonged Exposure) can be tailored to effectively treat moral injury-based PTSD while maintaining fidelity to the treatment protocols.
1. Recognize differences between acute and traumatic stress.
2. Recognize differences between moral injury-based PTSD and primarily fear-based PTSD among military service members and veterans.
3. Evaluate existing assessment tools for moral injury
4. Compare different evidence-based PTSD treatments and novel interventions for the treatment of moral injury-based PTSD
This webinar is eligible for CE.
Learners must complete an evaluation form to receive a certificate of completion. You must participate in the entire activity as partial credit is not available. If you are seeking continuing education credit for a specialty not listed below, it is your responsibility to contact your licensing/certification board to determine course eligibility for your licensing/certification requirement.
This course is co-sponsored by Amedco and Anxiety and Depression Association of American (ADAA). Amedco is approved by the American Psychological Association to sponsor continuing education for psychologists. Amedco maintains responsibility for this program and its content. 1.0 hours.
New York Board for Social Workers
Amedco SW CPE is recognized by the New York State Education Department’s State Board for Social Work as an approved provider of continuing education for licensed social workers #0115. 1.0 hours.
The Anxiety and Depression Association of American (ADAA) has been approved by NBCC as an Approved Continuing Education Provider, ACEP No. 6872. Programs that do not qualify for NBCC credit are clearly identified. ADAA is solely responsible for all aspects of the programs.
The CAMFT board accepts credits from providers approved by the American Psychological Association (APA).